Stephen Ubl, president and chief executive officer of PhRMA (Photographer: Andrew Harrer/Bloomberg via Getty Images)

Two sides of 'his­toric' drug pric­ing bill: Phar­ma in­dus­try blasts 'mis­take' while ad­vo­cates plan for 'first ever' gains

Both Con­gres­sion­al De­moc­rats and the phar­ma in­dus­try agree that pend­ing drug pric­ing leg­is­la­tion is “his­toric” — they just di­a­met­ri­cal­ly dis­agree on the mod­i­fi­er.

Trade in­dus­try group …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.